These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14676626)

  • 1. SHP-2 and myeloid malignancies.
    Tartaglia M; Niemeyer CM; Shannon KM; Loh ML
    Curr Opin Hematol; 2004 Jan; 11(1):44-50. PubMed ID: 14676626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis.
    Loh ML; Vattikuti S; Schubbert S; Reynolds MG; Carlson E; Lieuw KH; Cheng JW; Lee CM; Stokoe D; Bonifas JM; Curtiss NP; Gotlib J; Meshinchi S; Le Beau MM; Emanuel PD; Shannon KM
    Blood; 2004 Mar; 103(6):2325-31. PubMed ID: 14644997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia.
    Niihori T; Aoki Y; Ohashi H; Kurosawa K; Kondoh T; Ishikiriyama S; Kawame H; Kamasaki H; Yamanaka T; Takada F; Nishio K; Sakurai M; Tamai H; Nagashima T; Suzuki Y; Kure S; Fujii K; Imaizumi M; Matsubara Y
    J Hum Genet; 2005; 50(4):192-202. PubMed ID: 15834506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ-line and somatic PTPN11 mutations in human disease.
    Tartaglia M; Gelb BD
    Eur J Med Genet; 2005; 48(2):81-96. PubMed ID: 16053901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
    Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia.
    Tartaglia M; Martinelli S; Cazzaniga G; Cordeddu V; Iavarone I; Spinelli M; Palmi C; Carta C; Pession A; Aricò M; Masera G; Basso G; Sorcini M; Gelb BD; Biondi A
    Blood; 2004 Jul; 104(2):307-13. PubMed ID: 14982869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of PTPN11 are rare in adult myeloid malignancies.
    Hugues L; Cavé H; Philippe N; Pereira S; Fenaux P; Preudhomme C
    Haematologica; 2005 Jun; 90(6):853-4. PubMed ID: 15951301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.
    Chan RJ; Feng GS
    Blood; 2007 Feb; 109(3):862-7. PubMed ID: 17053061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.
    Loh ML; Reynolds MG; Vattikuti S; Gerbing RB; Alonzo TA; Carlson E; Cheng JW; Lee CM; Lange BJ; Meshinchi S;
    Leukemia; 2004 Nov; 18(11):1831-4. PubMed ID: 15385933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia.
    Yamamoto T; Isomura M; Xu Y; Liang J; Yagasaki H; Kamachi Y; Kudo K; Kiyoi H; Naoe T; Kojma S
    Leuk Res; 2006 Sep; 30(9):1085-9. PubMed ID: 16533526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3-bp deletion mutation of PTPN11 in an infant with severe Noonan syndrome including hydrops fetalis and juvenile myelomonocytic leukemia.
    Yoshida R; Miyata M; Nagai T; Yamazaki T; Ogata T
    Am J Med Genet A; 2004 Jul; 128A(1):63-6. PubMed ID: 15211660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G; Neuer K; Ranke MB; Wittekindt NE
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling.
    Uhlén P; Burch PM; Zito CI; Estrada M; Ehrlich BE; Bennett AM
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2160-5. PubMed ID: 16461457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease.
    Tartaglia M; Martinelli S; Stella L; Bocchinfuso G; Flex E; Cordeddu V; Zampino G; Burgt Iv; Palleschi A; Petrucci TC; Sorcini M; Schoch C; Foa R; Emanuel PD; Gelb BD
    Am J Hum Genet; 2006 Feb; 78(2):279-90. PubMed ID: 16358218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.
    Tartaglia M; Mehler EL; Goldberg R; Zampino G; Brunner HG; Kremer H; van der Burgt I; Crosby AH; Ion A; Jeffery S; Kalidas K; Patton MA; Kucherlapati RS; Gelb BD
    Nat Genet; 2001 Dec; 29(4):465-8. PubMed ID: 11704759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
    Henshall TL; Jones KL; Wilkinson R; Jackson DE
    J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.
    Tartaglia M; Niemeyer CM; Fragale A; Song X; Buechner J; Jung A; Hählen K; Hasle H; Licht JD; Gelb BD
    Nat Genet; 2003 Jun; 34(2):148-50. PubMed ID: 12717436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic PTPN11 mutations in childhood acute myeloid leukaemia.
    Tartaglia M; Martinelli S; Iavarone I; Cazzaniga G; Spinelli M; Giarin E; Petrangeli V; Carta C; Masetti R; Aricò M; Locatelli F; Basso G; Sorcini M; Pession A; Biondi A
    Br J Haematol; 2005 May; 129(3):333-9. PubMed ID: 15842656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia in an adult Noonan syndrome patient with PTPN11 mutation.
    Matsubara K; Yabe H; Ogata T; Yoshida R; Fukaya T
    Am J Hematol; 2005 Jun; 79(2):171-2. PubMed ID: 15929108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.